Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: Syringe purchase test study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Fedorova, Ekaterina V ^a   Skochilov, Roman V ^a,b   Heimer, Robert ^c   Case, Patricia ^d   Beletsky, Leo ^e   Grau, Lauretta E ^c   Kozlov, Andrey P ^a,b   Shaboltas, Alla V ^a,b  

^a Biomedical Center   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^c YALE UNIVERSITY   (United States)

^d FENWAY INSTITUTE   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

Author keywords

HIV prevention; Injection drug use; Pharmacy; Syringe access

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLASSIFICATION; COHORT ANALYSIS; COMMERCIAL PHENOMENA; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; MALE; METHODOLOGY; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; RUSSIAN FEDERATION; STATISTICS; SUBSTANCE ABUSE; SYRINGE;

ADULT; COHORT STUDIES; COMMERCE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PHARMACIES; PHARMACISTS; PROFESSIONAL PRACTICE LOCATION; QUALITATIVE RESEARCH; QUESTIONNAIRES; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

MLCS; MLOWN;

EID: 84874398014     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-183     Document Type: Article

References (36)

1. Goliusov AT, Dementyeva LA, Ladnaya NN, Briko NI, Tumanova MS, Korzhayeva NA, Semenchenko MV, Nitzsche-Bell A, Kobzeva VB, Country Progress Report of the Russian Federation on the Implementation of the Declaration of Commitment on HIV/AIDS Moscow, RF: Federal Service for Surveillance of Consumer Rights Protection and Human Well Being, Ministry of Health and Social Development 2008
2. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Rhodes T, Sarang A, Bobrik A, Bobkov A, Platt L, Internatl J Drug Policy 2004 15 1 16 10.1016/j.drugpo.2003.09.001
3. UNAIDS report on the global AIDS epidemic http://www.unaids.org/ globalreport
4. Pokrovsky VV, Ladnaya NN, Buravtsova EV, HIV Infection: Information bulletin #34 Moscow, RF: Russian Federal AIDS Center 2010 17046509
5. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP, Lancet 2008 372 1733 1745 10.1016/S0140-6736(08)61311-2 18817968
6. Estimation of the number of injection drug users in St. Petersburg, Russia. Heimer R, White E, Drug Alcohol Depend 2010 109 79 83 10.1016/j.drugalcdep.2009.12.010 20060238
7. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP, AIDS Behav 2010 14 932 941 10.1007/s10461-008-9469-y 18843531
8. Public Health Committee of St. Petersburg, HIV infection and chronic viral hepatitis in St. Petersburg in 2009 St. Petersburg, RF: Center for Infectious Disease Control and Prevention 2010
9. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St. Petersburg, Russia. Abdala N, Carney JM, Durante AJ, Klimov N, Ostrovski D, Somlai AM, Kozlov AP, Heimer R, Internatl J STD & AIDS 2003 14 697 703 10.1258/095646203322387965
10. The potential for bridging of HIV transmission in Russian Federation: Sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. Niccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R, J Urban Health 2009 86 131 S143 10.1007/s11524-009-9369-0
11. HIV prevalence, socio-demographic and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. Shaboltas AV, Toussova OV, Hoffman IF, Heimer R, Verevochkin SV, Ryder RW, Khoshnood K, Perdue T, Masse BR, Kozlov AP, J Acquir Immune Defic Syndr 2006 41 657 663 16652041
12. HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Beauchamp G, Sheldon W, Miller WC, Hoffman IF, AIDS 2006 20 901 906 10.1097/01.aids.0000218555.36661.9c 16549975
13. Verevochkin SV, Shaboltas AV, Gagarina SY, Skochilov RV, Toussova OV, Krasnoselskih TV, Malov SV, Kozlov AP, High HIV incidence rate in St. Petersburg IDU cohort Rome, Italy: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention: Abstract no. TUPE346 2011
14. Rapid increase in HIV rates-Orel oblast, Russian Federation, 1999-2001. Molotilov V, Sofronova R, Gusseynova N, Laricheva N, Hader SL, Garfein R, Paxton L, MMWR 2003 52 657 660 12869903
15. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Sarang A, Rhodes T, Platt L, Int J Drug Policy 2008 19 suppl1 25 36
16. Attitudes of police officers toward syringe access, occupational needle-sticks, and drug use: a qualitative study of one city police department in the Unites States. Beletsky L, Macalino G, Burris S, Int J Drug Policy 2005 16 267 274 10.1016/j.drugpo.2005.01.009
17. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Gostin LO, JAcquirImmuneDeficSyndrHumRetrovirol 1998 18 Suppl 1 60 S70
18. Syringe access for the prevention of bloodborne infections among injection drug users. Stancliff S, Agins B, Rich JD, Burris S, BMC Public Health 2003 3 37 10.1186/1471-2458-3-37 14633286
19. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs. Burns SM, Brettle RP, Gore SM, Peutherer JF, Robertson JR, J Infection 1996 32 53 62 10.1016/S0163-4453(96)80010-7
20. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. Case P, Beckett GA, Jones TS, JAcquirImmuneDeficSyndrHumRetrovirol 1998 18 Suppl 1 94 S101
21. A multistate trial of pharmacy syringe purchase. Compton WM, Horton JC, Cottler LB, Booth R, Leukefeld CG, Singer M, Cunningham-Williams R, Reich W, Fortuin Corsi K, Staton M, Fink JL, Stopka TJ, Spitznagel EL, J Urban Health 2004 81 661 670 10.1093/jurban/jth149 15466847
22. Changes in sources of syringes for injection drug users: impact of syringe deregulation. Deren S, Cleland C, Fuller CM, Kang SY, Des-Jarlais DC, Vlahov D, AIDS Behav 2006 10 717 721 10.1007/s10461-006-9096-4 16642418
23. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers - Connecticut, 1992-1993. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ, JAcquirImmuneDeficSyndrHumRetrovirol 1995 10 1 82 89
24. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D, Am J Public Health 2007 97 1 117 124 10.2105/AJPH.2005.069591 17138929
25. Citizens who inject drugs: the 'Fitpack' study. Lenton S, Kerry K, Loxley W, Tan-Quigley A, Greig R, Int J Drug Policy 2000 11 285 297 10.1016/S0955-3959(00)00061-X 10930791
26. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. Sheridan J, Strang J, Barber N, Glanz A, BMJ 1996 313 272 274 10.1136/bmj.313.7052.272 8704541
27. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD, J Urban Health 2010 87 942 953 10.1007/s11524-010-9503-z 21116724
28. Pharmacy syringe purchase test of non-prescription syringe sales in San Francisco and Los Angeles, 2010. Lutnick A, Cooper E, Dodson C, Bluthenthal R, Kral AH, J Urban Health 2012 in press
29. Policy reform to shift the health and human rights environment for vulnerable groups: the case of Kyrgyzstan's instruction 417. Beletsky L, Thomas R, Smelyanskaya M, Artamonova I, Shumskaya N, Dooronbekova A, Mukambetov A, Doyle H, Tolson R, Health and Hum Rights J 2012 14 2 1 15
30. Do criminal laws influence HIV risk behavior? An empirical trial. Burris SC, Beletsky L, Burleson JA, Case P, Lazzarini Z, Arizona St LJ 2007 39 467 517
31. Ministry of Health and Social Development of the Russian Federation, On minimal assortment of medicinal agents. Decree #351n of April 26th Moscow, RF: Ministry of Health and Social Development of the Russian Federation 2011
32. Open Health Institute, Harm Reduction Programs in the Civilian and Prison Sectors of the Russian Federation: Assessment of Best Practices Moscow, RF: Open Health Institute 2006
33. Quantum GIS Development Team, Quantum GIS Geographic Information System Open Source Geospatial Foundation Project 2010 http://qgis.osgeo.org
34. The population of the Russian Federation by cities, towns and urban areas on January 1, 2010 http://www.gks.ru
35. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties. Cooper EN, Dodson C, Stopka TJ, Riley ED, Garfein RS, Bluthenthal RN, J Urban Health 2010 87 543 552 10.1007/s11524-010-9483-z 20549568
36. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Des Jarlais DD, J Urban Health 2009 86 918 928 10.1007/s11524-009-9400-5 19921542